D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.67% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Regional Management Corp
RM
$306M
| $1.17M | ﹤0.01% |
34,304
+4,074
| +13% | +$128K |
|
2977
Krystal Biotech
KRYS
$9.62B
| $1.16M | ﹤0.01% |
7,427
-1,919
| -21% | -$340K |
|
|
FITB
2978
PUT
Fifth Third Bancorp
FITB
$51.8B
| $1.16M | ﹤0.01% |
27,500
| – | – |
|
2979
CEMIG Preferred Shares
CIG
$6.15B
| $1.16M | ﹤0.01% |
656,303
+91,762
| +16% | +$178K |
|
2980
PUT
Viasat
VSAT
$11.4B
| $1.16M | ﹤0.01% |
136,500
+8,800
| +7% | +$84.6K |
|
2981
Amylyx Pharmaceuticals
AMLX
$2.63B
| $1.16M | ﹤0.01% |
306,744
-384,322
| -56% | -$1.81M |
|
2982
PUT
Compass Minerals
CMP
$1.04B
| $1.16M | ﹤0.01% |
103,000
-200,500
| -66% | -$2.62M |
|
2983
Lazard
LAZ
$4.25B
| $1.16M | ﹤0.01% |
22,480
-2,900
| -11% | -$155K |
|
2984
Tactile Systems Technology
TCMD
$647M
| $1.15M | ﹤0.01% |
66,909
-43,465
| -39% | -$698K |
|
2985
Boston Properties
BXP
$11B
| $1.15M | ﹤0.01% |
15,400
-53,647
| -78% | -$4.35M |
|
2986
J. Jill
JILL
$283M
| $1.14M | ﹤0.01% |
41,307
-9,458
| -19% | -$244K |
|
2987
CALL
AstraZeneca
AZN
$249B
| $1.14M | ﹤0.01% |
8,700
-5,450
| -39% | -$763K |
|
2988
Compass Diversified
CODI
$819M
| $1.14M | ﹤0.01% |
+49,379
| New | +$1.11M |
|
2989
CALL
Symbotic
SYM
$5.12B
| $1.14M | ﹤0.01% |
47,900
+1,600
| +3% | +$45.5K |
|
|
ZYXI
2990
DELISTED
Zynex
ZYXI
| $1.13M | ﹤0.01% |
141,642
-29,517
| -17% | -$243K |
|
2991
BioNTech
BNTX
$22.7B
| $1.13M | ﹤0.01% |
9,950
-28,395
| -74% | -$3.24M |
|
2992
PUT
SharkNinja
SN
$25.4B
| $1.13M | ﹤0.01% |
11,600
-9,800
| -46% | -$1M |
|
2993
Anavex Life Sciences
AVXL
$303M
| $1.13M | ﹤0.01% |
+105,130
| New | +$809K |
|
2994
Commercial Vehicle Group
CVGI
$155M
| $1.13M | ﹤0.01% |
454,654
+120,996
| +36% | +$323K |
|
|
HONE
2995
DELISTED
HarborOne Bancorp
HONE
| $1.13M | ﹤0.01% |
95,121
+10,030
| +12% | +$127K |
|
2996
Iron Mountain
IRM
$36.6B
| $1.12M | ﹤0.01% |
+10,700
| New | +$1.26M |
|
2997
D-Wave Quantum Inc. Common Stock
QBTS
$7.31B
| $1.12M | ﹤0.01% |
+133,324
| New | +$399K |
|
2998
PUT
Enovix
ENVX
$940M
| $1.12M | ﹤0.01% |
117,714
-72,000
| -38% | -$632K |
|
2999
Vital Farms
VITL
$504M
| $1.12M | ﹤0.01% |
+29,687
| New | +$1.06M |
|
3000
Vera Bradley
VRA
$97.8M
| $1.12M | ﹤0.01% |
284,474
-99,930
| -26% | -$498K |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.